Skip to main content
Signal8

Oetgen Stephen Duane

SEC insider (Form 3/4/5 filer). CIK 0002126570. Director at Arxis, Inc. (ARXS). 2 reported Form 4/5 transactions since Sep 2024; latest on Apr 17, 2026. Located in BLOOMFIELD, CT.

Companies Oetgen Stephen Duane has filed insider reports for

  • Arxis, Inc. (ARXS): Director
Oetgen Stephen Duane profile photo

Oetgen Stephen Duane

CIK: 0002126570

Transaction Breakdown

Open Market Buys (P)1 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Arxis, Inc. logo
ARXS

Arxis, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Arxis, Inc. logo
    ARXS

    Arxis, Inc.

    Apr 17, 2026
    Award
    Direct
    5.4K shares-
  • Arxis, Inc. logo
    ARXS

    Arxis, Inc.

    Apr 17, 2026
    Purchase
    Direct
    25K shares at avg. $28.00$700K

1-2 of 2